As one of six products that the European regulator recommended for approval last Friday, Johnson & Johnson s (JNJ) new psoriasis treatment Stelara (...
Colgate-Palmolive (CL) is a relative latecomer to the downturn; shares have tumbled almost 25% over the past month as investors fret its once-touted e...
It was not very long ago that investors had become incredibly complacent about market risk. Over recent years, I have written a number of articles th...
Below we highlight the 25 largest companies in the US. As shown, Exxon Mobil (XOM) still holds the top spot, but there have been lots of other chang...
Google (GOOG), Campbell Soup (CPB), and Johnson & Johnson (JNJ) top the list of American companies that the US public sees as most socially responsibl...
The past two weeks were anything but easy for Rigel s (RIGL) shareholders, who saw their shares crash more than 50%. Rigel started 2008 on the right...
The past two weeks were anything but easy for Rigel s (RIGL) shareholders, who saw their shares crash more than 50%. Rigel started 2008 on the right...
Below we highlight consensus analyst price targets for the 30 stocks that make up the Dow Jones Industrial Average. As shown, Alcoa's (AA) price targe...
This year's market turbulence has many investors calling the buy and hold strategy dead. Let's prove them wrong. My musings (here and here) on holding...
Jeff Matthews Is Not Making This Up The World of Wall Street in all its glory, and anything else that strikes our fancy. Informed observations about comp...
Stock Market Beat Our beat is the stock market. Our job is to beat it....
TechCrunch TechCrunch profiles the companies, products and events that are defining and transforming the new web. TechCrunch is ...
Trader Mike Stock market commentary & trading ideas. Stock market weblog (blog), swing trading, day trading, stock picks, techni...
Subscribe On Your Mobile
Subscribe
.gif)
Environmental Economics
Paul Kedrosky's Infectious Greed
Jeff Matthews Is Not Making This Up
TechCrunch
Trader Mike
